Progenics Pharmaceuticals Announces First Quarter 2020 Financial Results and Business Update
Pending Merger with Lantheus Holdings, Inc. for Combination of an Innovative Commercial Life Sciences Company with a Diversified Precision Diagnostics and Radiopharmaceutical Therapeutics Portfolio Planned NDA Submission for PyLTM On Track for Early Third …